Tenon Medical Inc (NAS:TNON)

Q3 2025 Tenon Medical Inc Earnings Call Transcript

Nov 13, 2025 / 09:30 PM GMT

Release Date Price: $1.18 (-8.53%)

Transcript 10-Q

Key Points

Positve

Tenon Medical Inc (TNON) achieved record revenue of $1.2 million in Q3 2025, marking a 32% increase compared to the same period last year.
The integration of the iVantage portfolio significantly contributed to top-line growth, showcasing the success of Tenon Medical Inc (TNON)'s portfolio expansion strategy.
The acquisition of Cyvanage's Symmetry and Symmetry Plus sacroiliac Joint Fusion Technologies has been immediately accretive to revenue and enhances the company's ability to serve a wider range of physicians and patients.
The full commercial launch of the Catamaran FE SI joint fusion system strengthens Tenon Medical Inc (TNON)'s competitive position in the sacroiliac joint fusion market.
Tenon Medical Inc (TNON) ended the quarter with $3.4 million in cash and no debt, and subsequently raised an additional $2.85 million through a pipe financing to support future growth initiatives.

Negative

Operating expenses increased to $4.2 million in Q3 2025, up from $3.6 million in the prior year period, primarily due to higher sales expenses and integration efforts.
Net loss for the third quarter was $3.3 million, slightly higher than the $3.2 million loss in the same quarter of the previous year.
The company experienced a decrease in cash and cash equivalents, ending the quarter with $3.4 million compared to $6.5 million as of December 31, 2024.
The integration of Cyvanage's assets, while progressing well, still involves ongoing tactical tasks and efforts to fully integrate the customer and distributor base.
The launch of Symmetry Plus is initially limited to a pilot phase, which may delay broader market introduction and revenue generation from this new platform.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TNON.OQ - Tenon Medical Inc
Q3 2025 Tenon Medical Inc Earnings Call
Nov 13, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Tenant Medical 3rd quarter 2025 financial results and corporate update conference call. As a reminder, this call is being recorded. Your hosts today are Steve Foster, President and Chief Executive Officer, and Kevin Williamson, Chief Financial Officer. Mr. Foster and Mr. Williamson will present results of operations for the third quarter ended September 30th, 2025 and provide a corporate update.

A press release detailing these results was released today and is available on the investor relations, excuse me, investor relations section of our company's website at www.10. In med.com.

Before we begin the formal presentation, I'd like to remind everyone that statements made on the call and webcast

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.